GSK probe reveals bribes and lies2014-05-15
The bribery investigation of GlaxoSmithKline(GSK)China has been completed and the case handed over to prosecutors, Changsha police said on Wednesday.

GSK investigating staff2014-04-04
British pharmaceutical giant GlaxoSmithKline(GSK)has been investigating its employees in China and those found to have broken company compliance rules will be warned or even dismissed.

GSK vows to stop paying doctors to promote drugs2013-12-18
British drug company GlaxoSmithKline said Tuesday it would stop paying doctors to promote its products at speaking engagements and scrap individual sales targets, months after its ethics were challenged by a bribery scandal in China.

China might charge some local GSK execs: report2013-11-05
Chinese police investigating allegations of widespread corrupt practices at GlaxoSmithKline Plc(GSK)are likely to charge some of its Chinese executives but not the British drug maker itself, Reuters reported Monday, citing legal and industry sources.

Former China GSK boss remains in China assisting in probe2013-10-17
Mark Reilly, GlaxoSmithKline's former head of operations in China, is helping Chinese anti-corruption officials who are investigating allegations of extensive bribery by the drugmaker.

GSK denies it is considering leaving China2013-09-10
GlaxoSmithKleine, the British pharmaceu tical giant, said it was committed to China and denied media reports that it is considering pulling out over potential fines following a bribery scandal.

GSK scandal punishment must act as deterrent2013-09-09
Hundreds of hospitals in China are implicated in the GlaxoSmithKline bribery scandal but loose regulation is also to blame and tougher measures to supervise the industry are welcomed.

GSK's threat of China withdrawal, a bargaining chip?2013-09-09
GlaxoSmithKline is considering whether to pull out of China, where a criminal investigation has left the company facing a potential 20bn-yuan (2bn-pound) fine and the severance of ties with major hospitals.

Official responds over imported medicine pricing2013-09-08
A Chinese official has cited tax, additional pricing by hospitals and bloated circulation fees as the cause of high-end imported medicine to be sold at higher prices on the mainland than in Hong Kong.

Collaborating from within, foreign drug dealers find their way into China2013-09-06
An increasing number of international drug dealers are finding themselves Chinese girlfriends to make it easier to conduct their "business" in China.

Police reveals more about GSK China's violations2013-09-03
The Chinese police have recently revealed more details about suspected economic violations by GlaxoSmithKline (GSK) China.

Eli Lilly mired in bribery scandal2013-08-23
Pharmaceutical giant Eli Lilly, one of the world's biggest insulin producers, has been accused of systematically bribing physicians and hospitals in Shanghai to promote the sales of two of its insulin products, according to media reports.

Health authorities probe bribes to doctors2013-08-12
Health authorities have started to probe the alleged 1.69 million yuan ($276,000) in bribes from Sanofi-Aventis to 503 doctors in Beijing, Shanghai, Hangzhou and Guangzhou.

Pharm giant Sanofi-Aventis suspected of bribery2013-08-09
Allegations by a whistle-blower that French pharmaceutical giant Sanofi-Aventis bribed more than 500 doctors in China in late 2007 to boost its sales are being taken"very seriously"by the company.